Arix Bioscience plc 13D/13G Filings for Iterum Therapeutics plc (ITRM)

Arix Bioscience plc 13D and 13G filings for Iterum Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-06-05
4:31 pm
Sale
2020-06-02 13D Iterum Therapeutics plc
ITRM
Arix Bioscience plc 21,946
2.200%
-51,124decrease
(-69.97%)
Filing